Risk of severe pulmonary embolism in cancer patients receiving bevacizumab: Results from a meta-analysis of published and unpublished data.

Liu, Meidan; Zheng, Yayuan; Chen, Zuguang; Qiu, Yumiao; Pan, Zhanchun; Cai, Zitao; Shi, Yapeng; Cheng, Junfen; Yao, Weimin

Liu, Meidan; Zheng, Yayuan; Chen, Zuguang; Qiu, Yumiao; Pan, Zhanchun; Cai, Zitao; Shi, Yapeng; Cheng, Junfen; Yao, Weimin.

Afiliação

Liu M; 1 Institute of Respiratory Disease, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Zheng Y; 2 Laboratory of Physiological Sciences, Guangdong Medical University, Zhanjiang, China.
Chen Z; 1 Institute of Respiratory Disease, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Qiu Y; 1 Institute of Respiratory Disease, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Pan Z; 1 Institute of Respiratory Disease, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Cai Z; 1 Institute of Respiratory Disease, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Shi Y; 1 Institute of Respiratory Disease, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Cheng J; 3 Institute of Respiratory Disease, The Second People's Hospital of Zhanjiang, China.
Yao W; 1 Institute of Respiratory Disease, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

Tumour Biol ; 39(7): 1010428317714897, 2017 Jul.

Article em En | MEDLINE | ID: mdl-28714372

Assuntos

Bevacizumab/efeitos adversos; Neoplasias/tratamento farmacológico; Embolia Pulmonar/patologia; Inibidores da Angiogênese/efeitos adversos; Inibidores da Angiogênese/uso terapêutico; Anticorpos Monoclonais Humanizados/efeitos adversos; Anticorpos Monoclonais Humanizados/uso terapêutico; Bevacizumab/uso terapêutico; Feminino; Humanos; Masculino; Estadiamento de Neoplasias; Neoplasias/complicações; Neoplasias/epidemiologia; Neoplasias/patologia; Embolia Pulmonar/induzido quimicamente; Embolia Pulmonar/epidemiologia; Fatores de Risco

Palavras-chave

Bevacizumab; meta-analysis; pulmonary embolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Bevacizumab / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google